Promising Prospects For Post-Mugabe Investment

BMI View: Sub-Saharan Africa needs cheap, safe and effective drugs to manage its communicable disease burden and domestic drugmakers need investments of foreign currency. With economic growth rates in many African countries looking promising, investing in one of the few companies to reach internationally recognised production standards should be lucrative opportunity. Unfortunately, the talented pharmaceutical firm in question is in Zimbabwe, and currently the risks outweigh the

To read the full article, please choose one of the following options: